Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
Public ClinicalTrials.gov record NCT00672919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-Arm, Open-Label, Multicenter Study Evaluating the Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia Following Treatment Conversion From Rosiglitazone to Pioglitazone HCl in Combination With Stable Statin Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to measure the triglyceride changes in subjects with type 2 diabetes mellitus taking pioglitazone, once daily (QD), following treatment conversion from rosiglitazone.
Study identification
- NCT ID
- NCT00672919
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2003
- Primary completion
- Jul 31, 2004
- Completion
- Jul 31, 2004
- Last update posted
- Feb 27, 2012
2003 – 2004
United States locations
- U.S. sites
- 51
- U.S. states
- 28
- U.S. cities
- 51
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Bellflower | California | — | — |
| Not listed | Burlingame | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Pasadena | California | — | — |
| Not listed | Arvada | Colorado | — | — |
| Not listed | Norwalk | Connecticut | — | — |
| Not listed | Waterbury | Connecticut | — | — |
| Not listed | Aventura | Florida | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | North Miami Beach | Florida | — | — |
| Not listed | Tallahassee | Florida | — | — |
| Not listed | West Palm Beach | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Idaho Falls | Idaho | — | — |
| Not listed | Chicago Heights | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Des Moines | Iowa | — | — |
| Not listed | Lafayette | Louisiana | — | — |
| Not listed | Fall River | Massachusetts | — | — |
| Not listed | Waltham | Massachusetts | — | — |
| Not listed | Tupelo | Mississippi | — | — |
| Not listed | Chesterfield | Missouri | — | — |
| Not listed | Omaha | Nebraska | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Centerville | Ohio | — | — |
| Not listed | Dayton | Ohio | — | — |
| Not listed | Medford | Oregon | — | — |
| Not listed | Meadville | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Warwick | Rhode Island | — | — |
| Not listed | Chattanooga | Tennessee | — | — |
| Not listed | Morristown | Tennessee | — | — |
| Not listed | Murfreesboro | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | Arlington | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Midland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Ogden | Utah | — | — |
| Not listed | Orange | Virginia | — | — |
| Not listed | Virginia Beach | Virginia | — | — |
| Not listed | Man | West Virginia | — | — |
| Not listed | Wausau | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00672919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2012 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00672919 live on ClinicalTrials.gov.